|
Immunoenzyme Techniques
|
E05.601.470.350 |
|
|
Chemokine CXCL2
|
D12.644.276.374.200.120.100 |
|
|
Job Description
|
N04.452.677.410 |
|
|
Personnel Downsizing
|
N04.452.677.450 |
|
|
Proprotein Convertase 9
|
D08.811.277.656.300.760.718 |
|
|
Anti-Anxiety Agents
|
D27.505.954.427.210.950.015 |
|
|
Nonmuscle Myosin Type IIB
|
D12.776.220.525.475.475.500 |
|
|
Albuminuria
|
C23.888.942.750.269 |
|
|
Proteinuria
|
C23.888.942.750 |
|
|
Adrenarche
|
G08.686.841.374.204 |
|
|
Puberty
|
G08.686.841.374 |
|
|
Alginic Acid
|
D09.698.068.500 |
|
|
Alginates
|
D09.698.068 |
|
|
Plasma Substitutes
|
D27.505.954.502.140.500 |
|
|
Dickeya chrysanthemi
|
B03.660.250.139.500 |
|
|
Dickeya
|
B03.660.250.139 |
|
|
Kyasanur Forest Disease
|
C01.920.930.475 |
|
|
Nuclear Lamina
|
A11.284.835.514.700.500 |
|
|
Nuclear Envelope
|
A11.284.835.514.700 |
|
|
Oxalobacteraceae
|
B03.660.075.090.883 |
|
